NASDAQ: ANIXAnixa Biosciences Inc Stock Ownership - Who owns Anixa Biosciences?
Insider buying vs selling
Have Anixa Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Arnold M. Baskies | Director | 2026-01-28 | 10,000 | $3.04 | $30.40kBuy |
| Lewis H. Titterton Jr. | Director | 2025-12-15 | 16,000 | $2.92 | $46.72kBuy |
| Amit Kumar | Chief Executive Officer | 2025-10-30 | 200,000 | $2.92 | $584.00kBuy |
| Amit Kumar | Chief Executive Officer | 2025-10-30 | 169,439 | $4.06 | $687.92kSell |
| Lewis H. Titterton Jr. | Director | 2025-07-31 | 10,000 | $3.08 | $30.80kBuy |
| Amit Kumar | Chief Executive Officer | 2025-07-30 | 5,000 | $3.16 | $15.80kBuy |
| Arnold M. Baskies | Director | 2025-07-18 | 5,000 | $3.39 | $16.95kBuy |
| Lewis H. Titterton Jr. | Director | 2025-07-11 | 10,000 | $3.14 | $31.40kBuy |
| Amit Kumar | Chief Executive Officer | 2025-07-11 | 5,000 | $3.15 | $15.75kBuy |
| Amit Kumar | Chief Executive Officer | 2025-06-04 | 10,000 | $2.85 | $28.50kBuy |
ANIX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ANIX insiders and whales buy or sell their stock.
ANIX Shareholders
What type of owners hold Anixa Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Mars Overseas Ltd | 59.65% | 20,000,000 | $57.80M | Insider |
| Frank J. Disanto | 5.33% | 1,785,905 | $5.16M | Insider |
| Vanguard Capital Management LLC | 3.92% | 1,314,982 | $3.80M | Institution |
| Denis A. Krusos | 3.49% | 1,169,880 | $3.38M | Insider |
| Lewis H. Titterton Jr. | 2.89% | 969,334 | $2.80M | Insider |
| Tisha Stender | 2.39% | 800,000 | $2.31M | Insider |
| Amit Kumar | 1.82% | 610,486 | $1.76M | Insider |
| Bruce F. Johnson | 1.65% | 554,817 | $1.60M | Insider |
| Ubs Group Ag | 1.65% | 551,637 | $1.59M | Institution |
| Da Davidson Co | 1.61% | 539,272 | $1.56M | Institution |
ANIX vs Biotech Stocks
Anixa Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.